Ads
related to: pfizer
Search results
Pfizer wins $107.5 million from AstraZeneca in US cancer drug patent trial
Reuters· 5 days ago, opens new tab $107.5 million in damages, a Delaware federal jury said on Friday after finding that...
2 Top Growth Stocks Down 24% and 50% to Buy With $100
Motley Fool via Yahoo Finance· 6 days agoIf you have even $100 to invest in stocks right now, here are two top healthcare companies that the...
Spotlight on Pfizer: Analyzing the Surge in Options Activity - Pfizer (NYSE:PFE)
Benzinga· 6 days agoLoading... Loading... Deep-pocketed investors have adopted a bullish approach towards Pfizer PFE , and it's something market players shouldn't ignore. Our tracking of public ...
GSK Concealed Risk Associated With Discontinued Heart Burn Drug Zantac, Whistleblower Lawsuit Claims
Benzinga· 19 hours agoRelated: Pfizer Agrees To Settle Over 10,000 Lawsuits About Cancer Risks Associated With...
Pfizer offers up to $250 million to settle Zantac cancer lawsuits, FT reports By Reuters
Investing.com· 6 days agoThe drugmaker was set to pay between $200 million and $250 million in the settlement, the newspaper...
AstraZeneca sets sights on $80B in revenue by 2030
BioPharma Dive via Yahoo Finance· 1 day agoA decade ago, as British drugmaker AstraZeneca fought off a hostile takeover bid by Pfizer, CEO Pascal Soriot made a big promise: The company, he said,...
Pfizer Inc. (PFE) Is a Trending Stock: Facts to Know Before Betting on It
Zacks· 5 days agoFree Report) has recently been on Zacks.com's list of the most searched stocks. The Zacks Large Cap Pharmaceuticals industry, to which Pfizer belongs, has gained 6.3% over ...
European Patent Office Sides with Moderna In COVID-19 Vaccine Patent Dispute With Pfizer/BioNTech
Benzinga· 5 days agoModerna Inc MRNA has reportedly achieved a significant victory at the European Patent Office (EPO)...
Pfizer wins $107.5 million from AstraZeneca in US cancer drug patent trial
AOL· 5 days agoAstraZeneca owes Pfizer $107.5 million in damages, a Delaware federal jury said on Friday after finding that AstraZeneca's blockbuster lung cancer drug Tagrisso violated its ...
This overlooked obesity-drug stock has 80% upside, JPMorgan says
Business Insider via Yahoo Finance· 12 hours agoJPMorgan said early results suggest the drug candidate offers "on par" weight loss results for...